Eli Lilly Other current assets increased by 45.6% to $214.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 195.6%, from $72.40M to $214.00M. Over 3 years (FY 2022 to FY 2025), Other current assets shows an upward trend with a 172.1% CAGR.
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Standard across all industries; usually a minor component of the balance sheet.
current_assets_other_assets_current| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.30M | $149.50M | $138.60M | $142.20M | $134.60M | $266.00M | $72.40M | $68.80M | $271.50M | $147.00M | $214.00M |
| QoQ Change | — | >999% | -7.3% | +2.6% | -5.3% | +97.6% | -72.8% | -5.0% | +294.6% | -45.9% | +45.6% |
| YoY Change | — | >999% | — | — | — | +77.9% | -47.8% | -51.6% | +101.7% | -44.7% | +195.6% |